Avonex (Interferon beta 1a) ( DrugBank: Interferon beta 1a, Interferon beta )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,340 /  薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00501943 (ClinicalTrials.gov)	July 2006	12/7/2007	Neuroprotection With Riluzole Patients With Early Multiple Sclerosis	Neuroprotection With Riluzole in Patients With Early Multiple Sclerosis	Multiple Sclerosis	Drug: Avonex (Interferon beta 1a);Drug: Riluzole;Drug: Placebo	University of California, San Francisco	National Multiple Sclerosis Society;Oregon Health and Science University	Completed	18 Years	55 Years	All	43	Phase 2	United States